EDGAR Filing Documents for 0001558370-20-002551

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-20-002551

Filing Date

2020-03-12

Accepted

2020-03-12 16:38:58

Documents

Period of Report

2019-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	ymab-20191231x10k.htm	10-K	2816489
2	EX-4.4	ymab-20191231ex4400a47a7.htm	EX-4.4	42799
3	EX-23.1	ymab-20191231ex231246cbf.htm	EX-23.1	4498
4	EX-31.1	ymab-20191231ex311cf6c68.htm	EX-31.1	19463
5	EX-31.2	ymab-20191231ex312ef322c.htm	EX-31.2	19618
6	EX-32.1	ymab-20191231ex321c90ff8.htm	EX-32.1	7688
7	EX-32.2	ymab-20191231ex3228cf8c0.htm	EX-32.2	7401
8	GRAPHIC	ymab20191231x10k001.jpg	GRAPHIC	127079
9	GRAPHIC	ymab20191231x10k002.jpg	GRAPHIC	16757
10	GRAPHIC	ymab20191231x10k003.jpg	GRAPHIC	55776
11	GRAPHIC	ymab20191231x10k004.jpg	GRAPHIC	133296
12	GRAPHIC	ymab20191231x10k005.jpg	GRAPHIC	9830
13	GRAPHIC	ymab20191231x10k006.jpg	GRAPHIC	5983
14	GRAPHIC	ymab20191231x10k007.jpg	GRAPHIC	38035
15	GRAPHIC	ymab20191231x10k008.jpg	GRAPHIC	70940
16	GRAPHIC	ymab20191231x10k009.jpg	GRAPHIC	12330
17	GRAPHIC	ymab20191231x10k010.jpg	GRAPHIC	9975
18	GRAPHIC	ymab20191231x10k011.jpg	GRAPHIC	48655
19	GRAPHIC	ymab20191231x10k012.jpg	GRAPHIC	61241
	Complete submission text file	0001558370-20-002551.txt		8243409

Data Files

Seq	Description	Document	Type	Size
20	EX-101.INS	ymab-20191231.xml	EX-101.INS	1140814
21	EX-101.SCH	ymab-20191231.xsd	EX-101.SCH	54710
22	EX-101.CAL	ymab-20191231_cal.xml	EX-101.CAL	52404
23	EX-101.DEF	ymab-20191231_def.xml	EX-101.DEF	188263
24	EX-101.LAB	ymab-20191231_lab.xml	EX-101.LAB	470992
25	EX-101.PRE	ymab-20191231_pre.xml	EX-101.PRE	390171

Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017

Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841

Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)